Abstract
Purpose
Osteocalcin is considered as a bone-derived hormone affecting on the body fat distribution and body mass index. Several cross-sectional studies have investigated the association between serum osteocalcin and body mass index. The aim of this study was to summarize the evidence on the relationship between serum osteocalcin and body mass index.
Methods
We conducted a complete search up to November 2016 in PubMed and SCOPUS and reviewed reference list of all relevant articles and reviews. The DerSimonian–Laird method were used to pool effect sizes of eligible studies. The potential sources of heterogeneity were assessed using the standard χ 2 test.To find possible the sources of between-study heterogeneity, we carried out subgroup analyses based on sex, and type of study population.
Results
There was a significant inverse association in the overall result of this study between serum osteocalcin levels and BMI(r = −0.161; 95% CI: −0.197, −0.124, p < 0.000). In the subgroup analysis to find the sources of significant heterogeneity between-study, we observed that the type of the study population may be the source of between-study heterogeneity and the most correlation was seen in metabolic syndrome studies (r = −0.265; p = 0.000).
Conclusion
Findings from the available data indicated an overall significant inverse association between serum osteocalcin and body mass index. Further studies based on the type of study population are needed to better clarify these associations.
Similar content being viewed by others
References
R.J. Kuczmarski, K.M. Flegal, S.M. Campbell, C.L. Johnson, Increasing prevalence of overweight among US adults: the national health and nutrition examination surveys, 1960 to 1991. JAMA 272(3), 205–211 (1994)
L. Khaodhiar, K.C. McCowen, G.L. Blackburn, Obesity and its comorbid conditions. Clin. Cornerstone 2(3), 17–31 (1999)
T.T. Huang, A. Drewnowski, S.K. Kumanyika, T.A. Glass, A systems-oriented multilevel framework for addressing obesity in the 21st century. Prev. Chronic Dis. 6(3), A82 (2009)
C.B. Confavreux, R.L. Levine, G. Karsenty, A paradigm of integrative physiology, the crosstalk between bone and energy metabolisms. Mol. Cell. Endocrinol. 310(1), 21–29 (2009)
Y.-S. Kim, I.-Y. Paik, Y.-J. Rhie, S.-H. Suh, Integrative physiology: defined novel metabolic roles of osteocalcin. J. Korean Med. Sci. 25(7), 985–991 (2010)
J.R. Villafán-Bernal, S. SáNcHEz-ENRíqUEz, J.F. Muñoz-Valle, Molecular modulation of osteocalcin and its relevance in diabetes (Review). Int. J. Mol. Med. 28(3), 283 (2011)
A.R. Kang, Y.R. Oh, H.Y. Kim, M.J. Park, B.S. Joo, W.J. Choi, J.Y. Lee, M.H. Jung, Y.I. Ji, J.S. Choi, Up-regulation of inhibitors of DNA binding/differentiation gene during alendronate-induced osteoblast differentiation. Arch. Gynecol. Obstet. 285(5), 1331–1338 (2012)
M. Ferron, E. Hinoi, G. Karsenty, P. Ducy, Osteocalcin differentially regulates β cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc. Natl. Acad. Sci. 105(13), 5266–5270 (2008)
N.K. Lee, H. Sowa, E. Hinoi, M. Ferron, J.D. Ahn, C. Confavreux, R. Dacquin, P.J. Mee, M.D. McKee, D.Y. Jung, Endocrine regulation of energy metabolism by the skeleton. Cell 130(3), 456–469 (2007)
C. Foresta, G. Strapazzon, L. De Toni, L. Gianesello, A. Calcagno, C. Pilon, M. Plebani, R. Vettor, Evidence for osteocalcin production by adipose tissue and its role in human metabolism. J. Clin. Endocrinol. Metabol. 95(7), 3502–3506 (2010)
G. Strapazzon, L. De Toni, C. Foresta, Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus. Osteoporos. Int. 22(5), 1643–1644 (2011)
M. Zhou, X. Ma, H. Li, X. Pan, J. Tang, Y. Gao, X. Hou, H. Lu, Y. Bao, W. Jia, Serum osteocalcin concentrations in relation to glucose and lipid metabolism in Chinese individuals. Eur. J. Endocrinol. 161(5), 723–729 (2009)
A.G. Pittas, S.S. Harris, M. Eliades, P. Stark, B. Dawson-Hughes, Association between serum osteocalcin and markers of metabolic phenotype. J. Clin. Endocrinol. Metabol. 94(3), 827–832 (2009)
S. Bae, J. Choe, Y. Chung, B. Kim, S. Lee, H. Kim, J. Koh, H. Kim, G. Kim, The association between serum osteocalcin levels and metabolic syndrome in Koreans. Osteoporos. Int. 22(11), 2837–2846 (2011)
M. El-Eshmawy, I. Abdel Aal, Relationships between preptin and osteocalcin in obese, overweight, and normal weight adults. Appl. Physiol. Nutr. Metabol. 40(3), 218–222 (2015)
S.-H. Kim, J.-W. Lee, J.-A. Im, H.-J. Hwang, Serum osteocalcin is related to abdominal obesity in Korean obese and overweight men. Clin. Chim. Acta 411(23), 2054–2057 (2010)
G.S. Caglar, E.D. Ozdemir, M. Kiseli, S. Demirtas, S.D. Cengiz, The association of osteocalcin and adiponectin with glucose metabolism in nondiabetic postmenopausal women. Gynecol. Obstet. Invest. 77(4), 255–260 (2014)
Y. Bao, X. Ma, R. Yang, F. Wang, Y. Hao, J. Dou, H. He, W. Jia, Inverse relationship between serum osteocalcin levels and visceral fat area in Chinese men. J. Clin. Endocrinol. Metabol. 98(1), 345–351 (2012)
A. Tan, Y. Gao, X. Yang, H. Zhang, X. Qin, L. Mo, T. Peng, N. Xia, Z. Mo, Low serum osteocalcin level is a potential marker for metabolic syndrome: results from a Chinese male population survey. Metabolism 60(8), 1186–1192 (2011)
Y. Zhang, L. Qi, W. Gu, Q. Yan, M. Dai, J. Shi, Y. Zhai, Y. Chen, J. Liu, W. Wang, Relation of serum osteocalcin level to risk of coronary heart disease in Chinese adults. Am. J. Cardiol. 106(10), 1461–1465 (2010)
L.K. Trento, A. Pietropolli, C. Ticconi, E. Gravotta, M.U. De Martino, A. Fabbri, E. Piccione, Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women. J. Obstet. Gynaecol. Res. 35(1), 152–159 (2009). doi:10.1111/j.1447-0756.2008.00868.x
D.F. Stroup, J.A. Berlin, S.C. Morton, I. Olkin, G.D. Williamson, D. Rennie, D. Moher, B.J. Becker, T.A. Sipe, S.B. Thacker, Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 283(15), 2008–2012 (2000)
R.A. Fisher, Frequency distribution of the values of the correlation coefficient in samples from an indefinitely large population. Biometrika 10(4), 507–521 (1915)
J. Higgins, S.G. Thompson, Quantifying heterogeneity in a meta‐analysis. Stat. Med. 21(11), 1539–1558 (2002)
R. DerSimonian, N. Laird, Meta-analysis in clinical trials. Control Clin. Trials 7(3), 177–188 (1986)
M. Liao, X. Guo, X. Yu, G. Pang, S. Zhang, J. Li, A. Tan, Y. Gao, X. Yang, H. Zhang, X. Qin, L. Mo, Z. Lu, C. Wu, Z. Mo, Role of metabolic factors in the association between osteocalcin and testosterone in Chinese men. J. Clin. Endocrinol. Metab. 98(8), 3463–3469 (2013). doi:10.1210/jc.2013-1805
K. Bezerra dos Santos Magalhaes, M.M. Magalhaes, E.T. Diniz, C.S. Lucena, L. Griz, F. Bandeira, Metabolic syndrome and central fat distribution are related to lower serum osteocalcin concentrations. Ann. Nutr. Metab. 62(3), 183–188 (2013). doi:10.1159/000342561
M. Liao, L. Huang, Y. Mao, Y. Jiang, Z. Yao, X. Lin, Z. Lu, C. Wu, X. Qin, H. Zhang, Z. Mo, Serum osteocalcin is associated with inflammatory factors in metabolic syndrome: a population-based study in Chinese males. Mediators Inflamm. 2015, 683739 (2015). doi:10.1155/2015/683739
Z.M. Gonzalez-Garcia, I.J. Kullo, D.K. Coletta, L.J. Mandarino, G.Q. Shaibi, Osteocalcin and type 2 diabetes risk in Latinos: a life course approach. Am. J. Hum. Biol. 27(6), 859–861 (2015). doi:10.1002/ajhb.22745
M. El-Eshmawy, I. Abdel Aal, Relationships between preptin and osteocalcin in obese, overweight, and normal weight adults. Appl. Physiol. Nutr. Metab. 40(3), 218–222 (2015). doi:10.1139/apnm-2014-0338
W.W. Hu, Y.H. Ke, J.W. He, W.Z. Fu, Y.J. Liu, D. Chen, Z.L. Zhang, Serum osteocalcin levels are inversely associated with plasma glucose and body mass index in healthy Chinese women. Acta Pharmacol. Sin. 35(12), 1521–1526 (2014). doi:10.1038/aps.2014.92
K.Y. Chin, S. Ima-Nirwana, I.N. Mohamed, F. Ahmad, E.S. Ramli, A. Aminuddin, W.Z. Ngah, Serum osteocalcin is significantly related to indices of obesity and lipid profile in Malaysian men. Int. J. Med. Sci. 11(2), 151–157 (2014). doi:10.7150/ijms.7152
H.A. Weiler, J. Lowe, J. Krahn, W.D. Leslie, Osteocalcin and vitamin D status are inversely associated with homeostatic model assessment of insulin resistance in Canadian aboriginal and white women: the first nations bone health study. J. Nutr. Biochem. 24(2), 412–418 (2013). doi:10.1016/j.jnutbio.2011.12.007
B. Buday, F.P. Pach, B. Literati-Nagy, M. Vitai, Z. Vecsei, L. Koranyi, Serum osteocalcin is associated with improved metabolic state via adiponectin in females versus testosterone in males. Gender specific nature of the bone-energy homeostasis axis. Bone 57(1), 98–104 (2013). doi:10.1016/j.bone.2013.07.018
Y. Bao, X. Ma, R. Yang, F. Wang, Y. Hao, J. Dou, H. He, W. Jia, Inverse relationship between serum osteocalcin levels and visceral fat area in Chinese men. J. Clin. Endocrinol. Metab. 98(1), 345–351 (2013). doi:10.1210/jc.2012-2906
S.J. Bae, J.W. Choe, Y.E. Chung, B.J. Kim, S.H. Lee, H.Y. Kim, J.M. Koh, H.K. Kim, G.S. Kim, The association between serum osteocalcin levels and metabolic syndrome in Koreans. Osteoporos. Int. 22(11), 2837–2846 (2011). doi:10.1007/s00198-010-1504-y
Y. Zhang, L. Qi, W. Gu, Q. Yan, M. Dai, J. Shi, Y. Zhai, Y. Chen, J. Liu, W. Wang, G. Ning, J. Hong, Relation of serum osteocalcin level to risk of coronary heart disease in Chinese adults. Am. J. Cardiol. 106(10), 1461–1465 (2010). doi:10.1016/j.amjcard.2010.07.013
U. Saleem, T.H. Mosley Jr., I.J. Kullo, Serum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndrome. Arterioscler. Thromb. Vasc. Biol. 30(7), 1474–1478 (2010). doi:10.1161/atvbaha.110.204859
S.H. Kim, J.W. Lee, J.A. Im, H.J. Hwang, Serum osteocalcin is related to abdominal obesity in Korean obese and overweight men. Clin. Chim. Acta 411(23-24), 2054–2057 (2010). doi:10.1016/j.cca.2010.08.046
J.M. Kindblom, C. Ohlsson, O. Ljunggren, M.K. Karlsson, A. Tivesten, U. Smith, D. Mellstrom, Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men. J. Bone Miner. Res. 24(5), 785–791 (2009). doi:10.1359/jbmr.081234
E.M. Alissa, W.A. Alnahdi, N. Alama, G.A. Ferns, Serum osteocalcin is associated with dietary vitamin D, body weight and serum magnesium in postmenopausal women with and without significant coronary artery disease. Asia Pac. J. Clin. Nutr. 23(2), 246–255 (2014). doi:10.6133/apjcn.2014.23.2.06
L. Chen, Q. Li, Z. Yang, Z. Ye, Y. Huang, M. He, J. Wen, X. Wang, B. Lu, J. Hu, C. Liu, C. Ling, S. Qu, R. Hu, Osteocalcin, glucose metabolism, lipid profile and chronic low-grade inflammation in middle-aged and elderly Chinese. Diabet. Med. 30(3), 309–317 (2013). doi:10.1111/j.1464-5491.2012.03769.x
S.W. Lee, H.H. Jo, M.R. Kim, Y.O. You, J.H. Kim, Association between obesity, metabolic risks and serum osteocalcin level in postmenopausal women. Gynecol. Endocrinol. 28(6), 472–477 (2012). doi:10.3109/09513590.2011.633660
E.F. Papakitsou, A.N. Margioris, K.E. Dretakis, G. Trovas, U. Zoras, G. Lyritis, E.K. Dretakis, K. Stergiopoulos, Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women. Maturitas 47(3), 185–193 (2004). doi:10.1016/s0378-5122(03)00282-2
S.W. Lee, H.H. Jo, M.R. Kim, J.H. Kim, Y.O. You, Association between osteocalcin and metabolic syndrome in postmenopausal women. Arch. Gynecol. Obstet. 292(3), 673–681 (2015). doi:10.1007/s00404-015-3656-7
A. Movahed, B. Larijani, I. Nabipour, M. Kalantarhormozi, K. Asadipooya, K. Vahdat, S. Akbarzadeh, M. Farrokhnia, M. Assadi, R. Amirinejad, A. Bargahi, Z. Sanjdideh, Reduced serum osteocalcin concentrations are associated with type 2 diabetes mellitus and the metabolic syndrome components in postmenopausal women: the crosstalk between bone and energy metabolism. J. Bone Miner. Metab. 30(6), 683–691 (2012). doi:10.1007/s00774-012-0367-z
A. Neve, A. Corrado, F.P. Cantatore, Osteocalcin: skeletal and extra‐skeletal effects. J. Cell. Physiol. 228(6), 1149–1153 (2013)
M. Kawai, M.J. Devlin, C.J. Rosen Fat targets for skeletal health.Nat. Rev. Rheumatol. 5(7), 365–372 (2009)
E. Hinoi, N. Gao, D.Y. Jung, V. Yadav, T. Yoshizawa, M.G. Myers, S.C. Chua, J.K. Kim, K.H. Kaestner, G. Karsenty, The sympathetic tone mediates leptin’s inhibition of insulin secretion by modulating osteocalcin bioactivity. J. Cell. Biol. 183(7), 1235–1242 (2008)
G. Chamberlain, J. Fox, B. Ashton, J. Middleton, Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25(11), 2739–2749 (2007)
A. Garcia-Martin, M. Cortes-Berdonces, I. Luque-Fernandez, P. Rozas-Moreno, M. Quesada-Charneco, M. Munoz-Torres, Osteocalcin as a marker of metabolic risk in healthy postmenopausal women. Menopause 18(5), 537–541 (2011). doi:10.1097/gme.0b013e3181f8565e
M. Cifuentes, M.A. Johnson, R.D. Lewis, S.B. Heymsfield, H.A. Chowdhury, C.M. Modlesky, S.A. Shapses, Bone turnover and body weight relationships differ in normal-weight compared with heavier postmenopausal women. Osteoporos. Int. 14(2), 116–122 (2003). doi:10.1007/s00198-002-1324-9
C. Foresta, G. Strapazzon, L. De Toni, L. Gianesello, A. Bruttocao, A. Scarda, M. Plebani, A. Garolla, Androgens modulate osteocalcin release by human visceral adipose tissue. Clin. Endocrinol. (Oxf). 75(1), 64–69 (2011). doi:10.1111/j.1365-2265.2011.03997.x
C. Foresta, G. Strapazzon, L. De Toni, L. Gianesello, A. Calcagno, C. Pilon, M. Plebani, R. Vettor, Evidence for osteocalcin production by adipose tissue and its role in human metabolism. J. Clin. Endocrinol. Metab. 95(7), 3502–3506 (2010). doi:10.1210/jc.2009-2557
A.J. Lucey, G.K. Paschos, I. Thorsdottir, J.A. Martinez, K.D. Cashman, M. Kiely, Young overweight and obese women with lower circulating osteocalcin concentrations exhibit higher insulin resistance and concentrations of C-reactive protein. Nutr. Res. 33(1), 67–75 (2013). doi:10.1016/j.nutres.2012.11.011
L.E. Polgreen, D.R. Jacobs Jr., B.M. Nathan, J. Steinberger, A. Moran, A.R. Sinaiko, Association of osteocalcin with obesity, insulin resistance, and cardiovascular risk factors in young adults. Obesity (Silver. Spring) 20(11), 2194–2201 (2012). doi:10.1038/oby.2012.108
Acknowledgements
Each author acknowledges he/she has participated in the work in a substantive way and is prepared to take full responsibility for the work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no competing interests.
Rights and permissions
About this article
Cite this article
Kord-Varkaneh, H., Djafarian, K., khorshidi, M. et al. Association between serum osteocalcin and body mass index: a systematic review and meta-analysis. Endocrine 58, 24–32 (2017). https://doi.org/10.1007/s12020-017-1384-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-017-1384-4